Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 30;13(9):3038.
doi: 10.3390/nu13093038.

Dietary Bioactive Ingredients Modulating the cAMP Signaling in Diabetes Treatment

Affiliations
Review

Dietary Bioactive Ingredients Modulating the cAMP Signaling in Diabetes Treatment

Yanan Wang et al. Nutrients. .

Abstract

As the prevalence of diabetes increases progressively, research to develop new therapeutic approaches and the search for more bioactive compounds are attracting more attention. Over the past decades, studies have suggested that cyclic adenosine monophosphate (cAMP), the important intracellular second messenger, is a key regulator of metabolism and glucose homeostasis in diverse physiopathological states in multiple organs including the pancreas, liver, gut, skeletal muscle, adipose tissues, brain, and kidney. The multiple characteristics of dietary compounds and their favorable influence on diabetes pathogenesis, as well as their intersections with the cAMP signaling pathway, indicate that these compounds have a beneficial effect on the regulation of glucose homeostasis. In this review, we outline the current understanding of the diverse functions of cAMP in different organs involved in glucose homeostasis and show that a diversity of bioactive ingredients from foods activate or inhibit cAMP signaling, resulting in the improvement of the diabetic pathophysiological process. It aims to highlight the diabetes-preventative or -therapeutic potential of dietary bioactive ingredients targeting cAMP signaling.

Keywords: cAMP; diabetes; dietary bioactive ingredients; glucose homeostasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Coordination of various organs is required in the regulations of glucose homeostasis.
Figure 2
Figure 2
Schematic illustration of cAMP signaling pathway. Adcy: adenylyl cyclase; ATP: adenosine triphosphate; Epac: exchange proteins directly activated by cAMP; CREB: cAMP-response element binding protein; PDE: phosphodiesterase; PKA: protein kinase A.
Figure 3
Figure 3
cAMP signaling pathway in the regulation of glucose homeostasis in pancreatic β cells (a) and hepatocytes (b). Adcy: adenylyl cyclase; ATP: adenosine triphosphate; Epac: exchange proteins directly activated by cAMP; CREB: cAMP-response element binding protein; G6pase: glucose-6-phosphatase; PDE: phosphodiesterase; PEPCK: phosphoenolpyruvate carboxykinase; PKA: protein kinase A; MPC: mitochondrial pyruvate carrier.

References

    1. WHO Diabetes. [(accessed on 25 August 2021)]. Available online: https://www.who.int/health-topics/diabetes#tab=tab_1.
    1. Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
    1. Hashiesh H.M., Meeran M.F.N., Sharma C., Sadek B., Kaabi J.A., Ojha S.K. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications. Nutrients. 2020;12:2963. doi: 10.3390/nu12102963. - DOI - PMC - PubMed
    1. Adisakwattana S. Cinnamic Acid and Its Derivatives: Mechanisms for Prevention and Management of Diabetes and Its Complications. Nutrients. 2017;9:163. doi: 10.3390/nu9020163. - DOI - PMC - PubMed
    1. Wang X., Kang J., Liu Q., Tong T., Quan H. Fighting diabetes mellitus: Pharmacological and non-pharmacological approaches. Curr. Pharm. Des. 2020;26:4992–5001. doi: 10.2174/1381612826666200728144200. - DOI - PubMed